Skip to main content
. 2014 Jan 16;2014:769790. doi: 10.1155/2014/769790

(b)  

Per pts Per cycle
Events G1
 Abdominal pain 3 14
 Nausea-vomiting 8 20
 Gastric pain 4 4
 Diarrhea 5 8
 Stomatitis 2 2
 Asthenia 4 15
 Anemia 3 4
 Neutropenia
 Thrombocytopenia
 Leukopenia 4 11
 Transaminitis
 Dyspnoea 1 1
 Neuropathy 3 4
 Hand-foot syndrome 1 1
 Nail changes 1 1
 Muscular pain 3 5
 Total 40 90
Events G2
 Abdominal pain 4 4
 Nausea-vomiting 4* 4
 Diarrhea 1
 Stomatitis 1* 1
 Asthenia 8 10
 Dysgeusia 1 1
 Neutropenia 1
 Anemia 1 3
 Hand-foot syndrome 1 2
 Nail changes 2 2
 Total 22 29
Events G3
 Neutropenia 1** 2
 Thrombocytopenia 1 1
 Leukopenia
 Neuropathy 1*** 2
 Hand-foot syndrome 1**** 1
 Gamma GT increase 1 1
 Total 5 7
Events G4
 Neutropenia 1 1
 Febrile neutropenia 1 1
 Leukopenia 2 2
 Total 4 4

*In 1 patient vomiting and stomatitis Grade 2 determined a dose reduction of VRB at 20 mg thrice a week.

**In 1 patient Grade 3 neutropenia was associated to Grade 1 Leukopenia; no dose reduction was required.

***Grade 3 neuropathy determined a dose reduction of VRB at 20 mg thrice a week.

****Grade 3 hand-foot syndrome determined a dose reduction of CAPE at 500 mg twice a day, until complete recovery to Grade 1.

See details in the text.